HR 7486, the Protecting Hospitals from Disaster Act of 2026, requires Quality Improvement Organizations (QIOs) to help hospitals and specific healthcare facilities prepare for and respond to extreme weather events. The bill allocates $50 million from Medicare funds in fiscal year 2026 to support this QIO assistance. It directly affects hospitals, psychiatric hospitals, skilled nursing facilities, critical access hospitals, long-term care hospitals, rural emergency hospitals, and inpatient rehabilitation facilities. The key mechanism is mandating QIOs to provide preparedness support to these facilities using the dedicated funding.
S 2628, the Catastrophic Specialty Hospital Act of 2025, creates a new Medicare payment designation for long-term care hospitals specializing in spinal cord injury and acquired brain injury rehabilitation. Hospitals meeting strict criteria - such as having at least 80% of discharges for these conditions over three years, 175+ annual discharges per condition, 30% out-of-state patients, and research commitments - will receive special Medicare payments instead of standard rates. This directly affects qualifying specialized hospitals, changing how Medicare reimburses them for care. The designation lasts three years and requires annual renewal based on continued compliance with the criteria.
Medicaid VBPs for Patients Act or the MVP Act This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. ( Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.) The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes. Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to issue guidance on how state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.
S 2951, the Competitive Bidding Relief Act, extends current Medicare payment rates for durable medical equipment (DME) in non-rural areas through December 31, 2025, and delays a new payment rule until 2026. It directly affects Medicare beneficiaries and DME suppliers in non-rural communities by maintaining existing reimbursement rates. The bill modifies how the Medicare program calculates payments under Section 414.210(g)(9) of federal regulations, preventing immediate changes to payment structures. This provides temporary stability for DME providers while allowing the government time to implement future adjustments.
S 1227 (ABC Act) requires the Centers for Medicare & Medicaid Services and Social Security Administration to review and simplify eligibility processes, forms, and communications for Medicare, Medicaid, CHIP, and Social Security programs. It directly affects family caregivers - defined as individuals supporting people with disabilities or health needs - who often face duplicate paperwork and communication barriers when navigating these systems. Key provisions mandate reducing repeated information requests, improving website accessibility (including ADA compliance), cutting call wait times, providing translation services, and gathering input from caregivers and advocacy groups. The agencies must report findings and proposed improvements to Congress within two years, with follow-up reports every two years. This bill focuses on streamlining existing processes, not creating new benefits or funding.
HR 668 establishes a 3-year pilot program to coordinate healthcare between the Department of Veterans Affairs (VA) and Medicare for veterans enrolled in both systems (called "covered veterans"). It assigns each participating veteran a VA case manager to create personalized care plans, navigate VA and Medicare services, and coordinate medical records to improve access, outcomes, and cost efficiency. The program tracks specific metrics like care costs, patient satisfaction, and service gaps, and requires quarterly reports to Congress on its implementation and results. The pilot will operate across 3-5 VA facilities in diverse settings (rural, urban, medically underserved areas) to test coordination models before potentially expanding the approach.
The Hearing Device Coverage Clarification Act (S 983) requires the Centers for Medicare & Medicaid Services (CMS) to clarify that implanted active middle ear hearing devices are prosthetics - not hearing aids - so they fall under Medicare's prosthetic coverage instead of the hearing aid exclusion. This change would directly affect Medicare beneficiaries who use these specific devices, ensuring they qualify for coverage without being denied under current policy. CMS must issue this clarification within 60 days of the bill's enactment, referencing the existing regulatory definition of "prosthetic" from 42 CFR § 414.202. The bill does not create new benefits but removes a coverage barrier for these devices.
HR 3021, the Empowering Patient Choice of Medical Care Act, changes Medicare rules to expand access to outpatient hospital care. Starting January 1, 2026, the Health Secretary cannot block outpatient designation for a service solely because it might only be safe in an inpatient setting. This directly affects Medicare beneficiaries who would previously have been required to stay in a hospital for certain procedures now eligible for outpatient care. The bill removes a specific administrative barrier, allowing more flexibility for patients and providers without altering Medicare coverage or payment rates.
This bill amends Medicare rules to clarify when rural hospitals can apply for specific payment rates. It changes Section 1820 of the Social Security Act to allow hospitals to submit applications for redesignation (reapplying for payment rates) before the bill's enactment date, with those applications still valid after the law takes effect. The change directly affects rural hospitals seeking to qualify for enhanced Medicare reimbursement under existing programs. It does not create new funding or services but streamlines administrative timing for hospitals already pursuing these designations.
HR 7871 (MVP Act) updates Medicaid drug rebate rules to allow manufacturers to report multiple "best price points" for drugs sold under outcome-based payment arrangements, requiring these arrangements to be offered to all states. It clarifies how average manufacturer price is calculated for such drugs and exempts certain outcome-linked payments from anti-kickback laws. The bill also mandates a GAO study to assess whether these arrangements improve patient access, lower costs, and reduce disparities in drug coverage. This affects Medicaid programs nationwide, drug manufacturers, and patients receiving covered outpatient drugs under Medicaid.